Adrenocortical carcinoma

2 papers1 finding

In silico1

Effects

1

Clinical outcomes

downin humans1

1 study

Adrenocortical carcinoma impairs clinical outcomes in humans.
“adrenocortical carcinoma (ACC), where clinical outcomes are poorer in older patients”
Review
Adrenal tumors in the elderly
Endocrine-related cancer14 Jan 2026

Trial sponsors

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
2 trialsPhase 3120 people
National Cancer Institute
2 trialsPhase 281 people
Ottawa Regional Cancer Centre
1 trialPhase 230 people
University of Turin, Italy
1 trialPhase 230 people
Copenhagen University Hospital, Rigshospitalet
1 trialPhase 219 people
Children's Oncology Group
1 trialPhase 122 people
Anusha Kalbasi
1 trialPhase 118 people
Mayo Clinic
1 trialPhase 1

Funding

1 grant

National Cancer InstituteUS$354.7k

SBIR CONCEPT AWARD "THERAPEUTICS" - TARGETED DELIVERY OF FERROPTOSIS INDUCERS FOR TREATMENT OF ADRENOCORTICAL CARCINOMA
National Cancer InstituteQana TherapeuticsUS$354.7k2024–2025

Latest

3 in 12 months

Problemy Endokrinologii14 Sep

Prognostic research in endocrinology: design and common errors

ReviewBiomarkers

Endocrine-related Cancer14 Jan

Adrenal tumors in the elderly

ReviewMechanisms

Frontiers in Aging8 Dec

Estimation of biological aging based on T-cell differentiation trajectories: emerging and future avenues

Computational studyBiomarkers